Pharmacokinetics and brain uptake of lactoferrin in rats
- PMID: 16165165
- DOI: 10.1016/j.lfs.2005.05.085
Pharmacokinetics and brain uptake of lactoferrin in rats
Abstract
Lactoferrin (Lf) is an iron-binding glycoprotein belonging to the transferrin (Tf) family. Lf was reported to cross the blood brain barrier (BBB) via receptor-mediated transcytosis in an in vitro model of the BBB. In the present study, we compared the in vivo brain uptake of Lf with that of OX26, an anti-Tf receptor antibody, and Tf. These three proteins were radiolabeled with 125I and administered to rats by i.v. injection. We found that Lf was more rapidly eliminated from the blood compared with OX26 and Tf (The half-life of Lf was approximately 8 and 6 times shorter than that of OX26 and Tf, respectively; the area under the blood concentration-time curve of Lf was approximately 15 and 17 times smaller than that of OX26 and Tf, respectively), and mainly accumulated in the liver, spleen, and kidney. Markedly high brain uptake was observed for Lf relative to Tf and OX26. Lf might be useful as a ligand for facilitating drug delivery into the brain.
Similar articles
-
Transcytosis of protein through the mammalian cerebral epithelium and endothelium. III. Receptor-mediated transcytosis through the blood-brain barrier of blood-borne transferrin and antibody against the transferrin receptor.Exp Neurol. 1996 Nov;142(1):47-65. doi: 10.1006/exnr.1996.0178. Exp Neurol. 1996. PMID: 8912898
-
Pharmacokinetics and blood-brain barrier transport of an anti-transferrin receptor monoclonal antibody (OX26) in rats after chronic treatment with the antibody.Drug Metab Dispos. 1998 Sep;26(9):937-9. Drug Metab Dispos. 1998. PMID: 9733674
-
Targeting rat anti-mouse transferrin receptor monoclonal antibodies through blood-brain barrier in mouse.J Pharmacol Exp Ther. 2000 Mar;292(3):1048-52. J Pharmacol Exp Ther. 2000. PMID: 10688622
-
Brain iron homeostasis.Dan Med Bull. 2002 Nov;49(4):279-301. Dan Med Bull. 2002. PMID: 12553165 Review.
-
Drug delivery to the brain using an anti-transferrin receptor antibody.NIDA Res Monogr. 1992;120:202-17. NIDA Res Monogr. 1992. PMID: 1501686 Review. No abstract available.
Cited by
-
Intranasal delivery of rotigotine to the brain with lactoferrin-modified PEG-PLGA nanoparticles for Parkinson's disease treatment.Int J Nanomedicine. 2016 Dec 7;11:6547-6559. doi: 10.2147/IJN.S120939. eCollection 2016. Int J Nanomedicine. 2016. PMID: 27994458 Free PMC article.
-
Fungal Enzyme l-Lysine α-Oxidase Affects the Amino Acid Metabolism in the Brain and Decreases the Polyamine Level.Pharmaceuticals (Basel). 2020 Nov 17;13(11):398. doi: 10.3390/ph13110398. Pharmaceuticals (Basel). 2020. PMID: 33212812 Free PMC article.
-
Brain-Targeted Delivery of Pre-miR-29b Using Lactoferrin-Stearic Acid-Modified-Chitosan/Polyethyleneimine Polyplexes.Pharmaceuticals (Basel). 2020 Oct 15;13(10):314. doi: 10.3390/ph13100314. Pharmaceuticals (Basel). 2020. PMID: 33076502 Free PMC article.
-
Lactoferrin Protects against Methamphetamine Toxicity by Modulating Autophagy and Mitochondrial Status.Nutrients. 2021 Sep 25;13(10):3356. doi: 10.3390/nu13103356. Nutrients. 2021. PMID: 34684361 Free PMC article.
-
Iron and intracerebral hemorrhage: from mechanism to translation.Transl Stroke Res. 2014 Aug;5(4):429-41. doi: 10.1007/s12975-013-0317-7. Epub 2013 Dec 21. Transl Stroke Res. 2014. PMID: 24362931 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous